CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population

Paola Borgiani, Cinzia Ciccacci, Vittorio Forte, Elisabetta Siríanni, Lucía Novelli, Placido Bramanti, Giuseppe Novelli

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: It is known that warfarin treatment is problematic, due to its narrow therapeutic range and to the great interindividual variability. Numerous papers have shown the important contribution of CYP2C9 and VKORC1 genetic variants to this variability. Recently, a new SNP within the CYP4F2 gene was found associated with warfarin dose in the USA. Aims: The aim of our work was to replicate this study in the Italian population and to assess the new CYP4F2 variant relative contributionin explaining warfarin dose variability with respect to CYP2C9 and VKORC1 genetic variants togetherwith age and weight. Materials & methods: CYP4F2 rs2108622 genotyping was performed by allelic discrimination assay by TaqMan® technology. Analysis of variance and multiple linear regression analyses were carried out to examine the contribution of genetic and nongenetic factors. Results: Our TT patients require 5.49 mg/day versus 2.93 mg/day of our CC patients. Analysis of variance indicates that about 7% of mean weekly warfarin dose variance is explained by CYP4F2 genotype. Our linear regression model including CYP4F2, CYP2C9 and VKORC1 genetic variants, age and weight, explains 60.5% of the interindividual variability. Conclusion: Our data confirm and strengthen the role of this variant.

Original languageEnglish
Pages (from-to)261-266
Number of pages6
JournalPharmacogenomics
Volume10
Issue number2
DOIs
Publication statusPublished - 2009

Keywords

  • CYP4F2
  • Drug dosing
  • Genomic biomarkers
  • Mean weekly warfarin dose
  • MWWD
  • Pharmacogenetics
  • Pharmacogenomics
  • SNP
  • Warfarin

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine

Fingerprint Dive into the research topics of 'CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population'. Together they form a unique fingerprint.

Cite this